Ensysce Biosciences Probability of Future Pink Sheet Price Finishing Over 0.04
| ENSCWDelisted Stock | USD 0.01 0.0008 8.16% |
Ensysce |
Ensysce Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ensysce Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ensysce Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Ensysce Biosciences is not yet fully synchronised with the market data | |
| Ensysce Biosciences has some characteristics of a very speculative penny stock | |
| Ensysce Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (29.15 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Ensysce Biosciences generates negative cash flow from operations |
Ensysce Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ensysce Pink Sheet often depends not only on the future outlook of the current and potential Ensysce Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ensysce Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.2 M | |
| Cash And Short Term Investments | 12.3 M |
Ensysce Biosciences Technical Analysis
Ensysce Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Ensysce Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ensysce Biosciences. In general, you should focus on analyzing Ensysce Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Ensysce Biosciences Predictive Forecast Models
Ensysce Biosciences' time-series forecasting models is one of many Ensysce Biosciences' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Ensysce Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Ensysce Biosciences
Checking the ongoing alerts about Ensysce Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Ensysce Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Ensysce Biosciences is not yet fully synchronised with the market data | |
| Ensysce Biosciences has some characteristics of a very speculative penny stock | |
| Ensysce Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (29.15 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Ensysce Biosciences generates negative cash flow from operations |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in Ensysce Pink Sheet
If you are still planning to invest in Ensysce Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ensysce Biosciences' history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |